Page last updated: 2024-11-07

estrone and Vitiligo

estrone has been researched along with Vitiligo in 3 studies

Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.

Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Research Excerpts

ExcerptRelevanceReference
"The efficacy of MF in treatment of vitiligo was proven to be due to the stimulatory effect of melanocyte proliferation and melanin production via alpha-MSH."1.30Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture. ( Ichimiya, M, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muto, M2
Furumoto, H1
Ohmura, A1
Asagami, C1
Ichimiya, M2
Nagai, K1
Yokoyama, K1
Hamamoto, Y1

Other Studies

3 other studies available for estrone and Vitiligo

ArticleYear
Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture.
    The Journal of dermatology, 1995, Volume: 22, Issue:10

    Topics: Administration, Oral; Aged; Androstenediol; Androstenedione; Cytoplasmic Granules; Dermatologic Agen

1995
Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture.
    The Journal of dermatology, 1999, Volume: 26, Issue:8

    Topics: Adrenocorticotropic Hormone; Aged; alpha-MSH; Androstenediol; Androstenedione; Drug Combinations; Es

1999
Successful treatment of non-segmental vitiligo: systemic therapy with sex hormone-thyroid powder mixture.
    Hormone research, 2000, Volume: 54, Issue:5-6

    Topics: Adult; Aged; alpha-MSH; Androstenediol; Androstenedione; Drug Combinations; Drug Resistance; Estrone

2000